Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

The use of vancomycin as part of the initial antibiotic therapy of febrile neutropenic patients has become a controversial issue. Some studies support its incorporation in the initial regimen, and others suggest that vancomycin can be added later. We examined this issue in a prospective, randomized...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ramphal, R, Bolger, M, Oblon, D J, Sherertz, R J, Malone, J D, Rand, K H, Gilliom, M, Shands, J W, Kramer, B S
Формат: Artigo
Язык:Inglês
Опубликовано: 1992
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC188836/
https://ncbi.nlm.nih.gov/pubmed/1510394
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы